Cambrian Bio

Cambrian Bio

Biotechnology Research

New York, New York 10,430 followers

Creating therapeutics that have the potential to treat and prevent some of today’s most debilitating chronic diseases

About us

Cambrian Bio is a clinical-stage drug development company building the medicines that will modernize healthcare in the 21st century. Our focus lies in creating innovative therapeutics designed to prevent diseases and lengthen healthspan—the period of life spent in good health. As a Distributed Development Company (or DisCo), Cambrian is advancing multiple scientific breakthroughs, each targeting a biological driver of aging. Our approach is to develop interventions that treat specific diseases first, then deploy them as preventative medicines to improve quality of life/overall quality of life as we age. To date, we have more than a dozen programs (PipeCos) in our pipeline, including Amplifier Therapeutics (developing a peripherally restricted pan-AMPK activator for the treatment of cardiometabolic diseases), Tornado Therapeutics (developing safer, more effective mTOR inhibitors for extended healthspan), and our latest addition, Telos Biotech (enhancing cell therapies to overcome senescence and exhaustion). We also has programs focused on Women’s Health and Aging (Oviva Therapeutics), Fibrosis (Isterian Biotech), and cellular engineering (Vita Therapeutics).

Website
http://www.cambrianbio.com
Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
New York, New York
Type
Privately Held
Founded
2019
Specialties
Biotech, Longevity, Longevity Science, Aging, Aging Biology, Geroscience, Healthspan, Disease Prevention, Healthcare, Pharma, innovation, and Science

Locations

Employees at Cambrian Bio

Updates

  • Cambrian Bio reposted this

    View profile for Margaret Kurtz, graphic

    Senior Director @ Cambrian Bio | Business Focused HR Leadership, People Strategy, Organizational Development

    Cambrian Bio is growing, and we’re looking for a Senior Manager/Director of Accounting to join our Accounting team and help drive our financial operations. If you’re a CPA with biotech experience and a passion for finance in a fast-paced environment, we want to hear from you! Learn more and apply here: https://lnkd.in/d4PNehzT #Hiring #AccountingJobs #Biotech #Finance #JoinOurTeam

  • Cambrian Bio reposted this

    View profile for James Peyer, PhD, graphic
    James Peyer, PhD James Peyer, PhD is an Influencer

    CEO at Cambrian Bio - creating the new generation of preventative medicines

    So much of the conversation around discoveries in aging biology has revolved around concierge medicine treatments, multimillionaires paying millions per year for their healthcare.    Luckily for the rest of us, the more validation a medicine has and the more people use it, the cheaper it is for everybody. Medicines with the potential to prevent multiple age-related diseases could perhaps be both the most affordable medicines in history and also the most profitable for the businesses that discover and develop them.    How? The demand curve. Not sufficiently clear? Check out the Cambrian Explosion newsletter for more context. #Longevity #DiseasePrevention

    Medicines that prevent the diseases of aging will be affordable and accessible

    Medicines that prevent the diseases of aging will be affordable and accessible

    James Peyer, PhD on LinkedIn

  • Cambrian Bio reposted this

    View profile for James Peyer, PhD, graphic
    James Peyer, PhD James Peyer, PhD is an Influencer

    CEO at Cambrian Bio - creating the new generation of preventative medicines

    I'm launching ‘Cambrian Explosion’, - a newsletter where I’ll be giving an insider’s perspective on biotech and the science of aging. I'm fascinated by the Cambrian period, 538 to 485 million years ago, which saw larger and faster changes to life than at any other point in life's 3.7 billion year history. The explosion gave Earth its first eyes, legs, arms, mouths, and even the idea of a symmetrical body plan. Interestingly, with all that new complexity, those animal bodies became more and more temporary. The Cambrian Explosion also gives us the first evidence of the diseases of aging in the fossil record. It was a dynamic time that rhymes with our current period of dramatic change, where our expanded knowledge of biology is giving us unprecedented control over our bodies. In this inaugural segment, I dive into why I think the first #aging drugs will find their first approvals for #obesity, and the implications I think it will have on our field moving forward. This newsletter is meant to be my own thinking and I try to be a bit more provocative here, so the views I express might not always reflect the position of Cambrian Bio, which is much larger than me alone.

    Preventatives targeting aging biology are coming soon...er than expected

    Preventatives targeting aging biology are coming soon...er than expected

    James Peyer, PhD on LinkedIn

  • Happy International Women’s day! Here are some fun facts about women’s health: • It wasn’t until 1993 that inclusion of both sexes was required in clinical trials in the U.S. • Up until 2016, when the NIH mandated both sexes be included in all studies of grant recipients, biomedical research had been conducted primarily in male animals. • In 2018, only 15% of the NIH budget was allocated to all of women’s health. These gaps have led to poorer health outcomes for women across all aspects of healthcare. But today, as we celebrate women and the progress made, let's remember that our work isn't done. We must continue pushing for a future where women's health is prioritized, ensuring that every woman receives the care she deserves. You can learn more about the historical disparities of women’s health on the Oviva Therapeutics website. While you're there, be sure to explore the incredible work they're doing to improve women’s health through groundbreaking biomedical research! https://lnkd.in/eXXfy9T4 Daisy Robinton, PhD #womenshealth #womensday2024

    About

    About

    ovivatx.com

Similar pages

Browse jobs

Funding

Cambrian Bio 6 total rounds

Last Round

Secondary market
See more info on crunchbase